Brief Article
Copyright ©2013 Baishideng Publishing Group Co.
World J Gastroenterol. Aug 28, 2013; 19(32): 5334-5339
Published online Aug 28, 2013. doi: 10.3748/wjg.v19.i32.5334
Table 3 Prevalence of dysmetabolic diseases and biochemical abnormalities in the 677 patients diagnosed with fatty liver n (%)
Patients examinedPositive patients
Increased ALT and/or AST levels676199 (29.4)
Hypertriglyceridemia635197 (31.0)
Mixed type hyperlipidemia635135 (21.3)
Hypercholesterolemia63592 (14.5)
Hyperglycemia640116 (18.1)
Hypertension636102 (16.0)
Gallstone67797 (14.4)
Hyperuricemia62787 (13.9)
HBsAg50639 (7.7)
Increased Scr levels5073 (0.6)